Recursion Pharmaceuticals (RXRX) Stock Moves -0.74%: What You Should Know

Zacks Oct 16 05:30

Down 57% in 2024, Is Recursion Pharmaceuticals a Buy on the Dip?

Yahoo FinanceOct 15 17:51

Recursion, Exscientia Seek Support for Merger Ahead of Special Meeting

Seeking AlphaOct 10 20:26

Why Recursion Is Getting Love as an AI and Drug Discovery Top Pick

Seeking AlphaOct 10 02:41

Cathie Wood's ARK Sheds Robinhood Stock, Adds to Amazon and Coinbase

InvestingOct 9 08:10

KeyBanc Maintains Recursion Pharmaceuticals(RXRX.US) With Buy Rating, Maintains Target Price $12

Futu NewsOct 3 06:32 · Ratings